METHOD FOR DETERMINING MANAGEMENT TACTICS OF PATIENTS WHO MAKE THE RISK GROUP OF DETECTING SQUAT CELLULAR INTRAEPITELIAL LESIONS OF THE UTERINE CERVIC Russian patent published in 2021 - IPC G01N33/50 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, in particular to obstetrics and gynecology, and is intended to determine the tactics of managing patients who are at risk of detecting squamous intraepithelial lesions of the cervix. In patients with an HPV-positive test and no cytological changes or with cytological findings of the ASC-US type, an optical-electric study is additionally performed using the LuViva system. The conclusion of the LuViva study is characterized as a low or high risk of detecting cervical intraepithelial lesions. At low risk, the absence of intraepithelial lesions is determined and the examination is continued according to the screening algorithm. If the risk is high, colposcopy and biopsy are done immediately.

EFFECT: invention provides high sensitivity of the method, a decrease in the number of unreasonable colposcopic studies and cervical biopsies, an immediate automated result that minimizes the subjectivity of the study.

1 cl, 2 ex